Skip to content
PubMed This is a summary of 18 peer-reviewed journal articles Updated
Gynecology

What Does Chronic Inflammation Mean on a Pap or Biopsy?

At a Glance

Chronic inflammation or chronic cervicitis on a Pap smear or cervical biopsy describes immune cells responding to infection, irritation, or healing; it does not by itself mean precancer or cancer. The final interpretation and high-risk HPV status guide follow-up.

Seeing the words “chronic inflammation” or “chronic cervicitis” on your Pap smear or cervical biopsy report can be alarming. However, these terms simply describe your body’s immune response under a microscope [1]. They mean the pathologist saw immune cells reacting to irritation, an infection, or a healing process [1]. By themselves, these words are descriptive findings—they do not mean you have cervical precancer or cancer [1].

To understand what your report actually means for your health, it helps to distinguish between a Pap smear (which screens shed cells) and a biopsy (which diagnoses actual tissue), and to look at the “final interpretation” rather than just the descriptive terminology.

The Final Interpretation Matters Most

Pathology reports usually contain a “Final Diagnosis” or “Interpretation” section. This is the most important part of the report.

  • On a Pap Smear (Cytology): Laboratories use a system called Bethesda to classify the cells. If your cells are healthy, the report will typically say NILM (Negative for Intraepithelial Lesion or Malignancy) [2]. If there are abnormalities, it will use acronyms like ASC-US, LSIL, HSIL, or AGC [3][4]. Inflammation can easily coexist with these abnormal findings, so it is crucial to look at the final Bethesda category, not just the word “inflammation” [3].
  • On a Cervical Biopsy (Histology): A biopsy looks at a physical piece of tissue. Precancerous changes here are graded as CIN (Cervical Intraepithelial Neoplasia, graded 1 to 3) or AIS (Adenocarcinoma in situ), while actual cancer is termed invasive carcinoma [5].

If your final interpretation is NILM on a Pap smear, or shows no CIN/dysplasia on a biopsy, the inflammation is generally considered a benign (non-cancerous) finding [1].

Translating the Pathology Jargon

Your report may include specific terms describing the cells involved in the inflammation or the healing process:

  • Neutrophils: White blood cells indicating an active, recent (acute) irritation or infection [6].
  • Lymphocytes and Plasma Cells: White blood cells that typically indicate a longer-term (“chronic”) immune response [7].
  • Follicular cervicitis: A specific pattern where immune cells cluster together to fight irritation. It is a type of inflammation, not a precancer [8].
  • Squamous metaplasia: A usually benign, normal process where one type of mature cervical cell is replaced by another to better protect the cervix [9].
  • Reactive atypia: Cells that look unusual because they are actively repairing themselves from inflammation or stress [9]. While they can sometimes mimic abnormal cells, they are not cancer [9].
  • Koilocytosis: Physical changes in cells that are often caused by the Human Papillomavirus (HPV) [10]. While it is a hint of a viral infection and requires clinical follow-up, it is interpreted in the context of your final diagnosis (such as LSIL) and is not, by itself, proof of cancer [8][4].

The Big Picture: Risk-Based Follow-Up

In modern cervical care, your doctor uses a “risk-based framework” (such as the ASCCP guidelines in the U.S.) to decide your next steps [11]. They do not rely on the word “inflammation” alone. Instead, they look at several factors:

  • Your High-Risk HPV (hrHPV) Status: This is a critical factor for determining cervical cancer risk [11]. If you have inflammation but are negative for hrHPV, your risk for cervical cancer is very low. If you test positive for a high-risk strain (like HPV 16 or 18), guidelines generally recommend further evaluation, such as a colposcopy (a magnified exam of the cervix), even if your Pap smear is otherwise normal [12][2].
  • Your Personal Context: Your age, previous Pap results, treatment history, and pregnancy status strongly influence whether you need immediate testing or simply a follow-up test in a year [11].
  • The Transformation Zone: This is the area on your cervix where most abnormal cells start to develop. If your Pap report notes “absent transformation zone cells,” it means the brush didn’t capture cells from this specific area [13]. This does not automatically make the test invalid or mean you need an immediate repeat; your doctor will decide based on your age and HPV status [13].
  • Endocervical Sampling: If you are having a colposcopy and have a Type 3 Transformation Zone (where the zone has receded high into the cervical canal), your doctor might recommend an endocervical curettage (ECC) [14]. This is a specialized sampling procedure of the canal to ensure no abnormalities are missed [14].

Symptoms and Infections: When to Seek Care

A negative HPV test is highly reassuring for cancer risk, but it does not evaluate for other causes of inflammation [2]. Chronic cervicitis can be caused by sexually transmitted infections (like chlamydia, gonorrhea, trichomoniasis, or Mycoplasma genitalium), common vaginal imbalances, or non-infectious irritation [15][16][17].

Do not assume that “inflammation” requires immediate antibiotics or that it is just a yeast infection. You and your doctor may need to test for specific infections based on your symptoms and history.

Actionable safety advice: Never ignore alarming symptoms just because a Pap smear was negative. Seek clinical evaluation if you experience new or persistent abnormal discharge, pelvic pain, or bleeding after sex [18][16]. Seek prompt or urgent medical care if you experience heavy bleeding, severe pain, or a high fever [18].

Common questions in this guide

Does chronic inflammation on a Pap smear mean I have cancer?
Usually, no. Chronic inflammation or chronic cervicitis describes immune cells responding to irritation, infection, or healing and does not by itself indicate precancer or cancer. The final Pap interpretation or biopsy diagnosis is what determines whether abnormal cells were found.
How is inflammation on a Pap smear different from inflammation on a cervical biopsy?
A Pap smear examines cells shed from the cervix for screening, while a cervical biopsy examines a small piece of tissue for diagnosis. Pap results may use categories such as NILM, ASC-US, LSIL, or HSIL, while biopsy results may describe CIN, AIS, or invasive carcinoma.
If my report says NILM or no CIN, is the inflammation benign?
If the final Pap interpretation is NILM, or if a biopsy shows no CIN or dysplasia, the inflammation is generally considered a benign, noncancerous finding. You may still need follow-up based on your high-risk HPV status, age, previous results, and medical history.
Can an infection cause chronic cervicitis?
Yes. Chlamydia, gonorrhea, trichomoniasis, and Mycoplasma genitalium can be associated with cervicitis, and vaginal imbalances or noninfectious irritation can also contribute. Testing should be chosen with a clinician based on your symptoms and history; a negative high-risk HPV test does not rule out these other causes.
How does high-risk HPV affect follow-up when inflammation is present?
High-risk HPV status is a major factor in deciding follow-up. A positive result, especially for HPV 16 or HPV 18, may lead to closer evaluation such as colposcopy even when the Pap result is otherwise normal, while a negative result is reassuring for cervical cancer risk. HPV testing does not evaluate every cause of inflammation.
When should I seek medical care for chronic inflammation?
Contact a clinician for new or persistent abnormal discharge, pelvic pain, or bleeding after sex, even if a Pap test was negative. Seek prompt or urgent care for heavy bleeding, severe pain, or high fever.
Should I worry if my Pap report says transformation zone cells were absent?
Not necessarily. This means the sample did not include cells from the area where many cervical abnormalities begin, but it does not automatically make the test invalid or require an immediate repeat. Your age, HPV status, and prior results determine the next step.

Questions For You

Answer a question to get research tailored to you. Your answers are private.

Get notified when new evidence is published on chronic cervicitis.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.What is the exact final interpretation (e.g., NILM, ASC-US, LSIL, or CIN) of my report, beyond just the descriptive words?
  2. 2.Given my high-risk HPV status, age, and previous test history, which clinical guideline pathway applies to my follow-up?
  3. 3.Should we test for specific infections like chlamydia, gonorrhea, trichomoniasis, or Mycoplasma genitalium based on this chronic inflammation?
  4. 4.Was the transformation zone adequately sampled, and if not, does my specific medical history require us to repeat the test or perform endocervical sampling?
  5. 5.If treatment for an infection is recommended, does my partner also need to be tested or treated?

References

References (18)
  1. 1

    Correlation of Cervical Pap Smear with Biopsy in the Lesion of Cervix.

    Dhakal R, Makaju R, Sharma S, et al.

    Kathmandu University medical journal (KUMJ) 2016; (14(55)):254-257.

    PMID: 28814689
  2. 2

    Immediate risk of cervical intraepithelial neoplasia and diagnostic value of colposcopy among cytology-negative women with oncogenic HPV: a retrospective study.

    Dai W, Wang T, Chen L, et al.

    BMC women's health 2024; (24(1)):419 doi:10.1186/s12905-024-03258-x.

    PMID: 39049047
  3. 3

    Diagnostic Approach to Patients with Atypical Squamous Cells of Undetermined Significance Cytologic Findings on Cervix.

    Jahic M, Jahic E

    Medical archives (Sarajevo, Bosnia and Herzegovina) 2016; (70(4)):296-298 doi:10.5455/medarh.2016.70.296-298.

    PMID: 27703293
  4. 4

    p16/Ki-67 dual-stained cytology used for triage in cervical cancer opportunistic screening.

    Han Q, Guo H, Geng L, Wang Y

    Chinese journal of cancer research = Chung-kuo yen cheng yen chiu 2020; (32(2)):208-217 doi:10.21147/j.issn.1000-9604.2020.02.08.

    PMID: 32410798
  5. 5

    The Pap smear in inflammation and repair.

    Kamal MM

    CytoJournal 2022; (19()):29 doi:10.25259/CMAS_03_08_2021.

    PMID: 35673696
  6. 6

    Cervicitis: a prospective observational study of empiric azithromycin treatment in women with cervicitis and non-specific cervicitis.

    Lusk MJ, Garden FL, Cumming RG, et al.

    International journal of STD & AIDS 2017; (28(2)):120-126 doi:10.1177/0956462416628319.

    PMID: 26792283
  7. 7

    Russell body cervicitis: A case report and literature review highlighting diagnostic pitfalls.

    De Silva L, Udeshika K, De Silva S, Amarathunga P

    Case reports in women's health 2025; (46()):e00707 doi:10.1016/j.crwh.2025.e00707.

    PMID: 40297197
  8. 8

    Cervicitis: How Often Is It Non-specific!

    Jayakumar NK

    Journal of clinical and diagnostic research : JCDR 2015; (9(3)):EC11-2 doi:10.7860/JCDR/2015/11594.5673.

    PMID: 25954624
  9. 9

    Cervical Pre-cancers: Biopsy and Immunohistochemistry.

    Kamal M

    CytoJournal 2022; (19()):38 doi:10.25259/CMAS_03_13_2021.

    PMID: 35928531
  10. 10

    Analysis of Distributions of HPV Infection in Females with Cervical Lesions in the Western District of Beijing Chaoyang Hospital.

    Gong M, Chen C, Zhao H, et al.

    Journal of healthcare engineering 2022; (2022()):5422748 doi:10.1155/2022/5422748.

    PMID: 35320994
  11. 11

    Cervical Cancer Screening: A Review.

    Perkins RB, Wentzensen N, Guido RS, Schiffman M

    JAMA 2023; (330(6)):547-558 doi:10.1001/jama.2023.13174.

    PMID: 37552298
  12. 12

    Diagnostic value of colposcopy in patients with cytology-negative and HR-HPV-positive cervical lesions.

    Liu Y, Liao J, Yi X, et al.

    Archives of gynecology and obstetrics 2022; (306(4)):1161-1169 doi:10.1007/s00404-022-06415-5.

    PMID: 35320389
  13. 13

    Tritesting in Battor, Ghana: an integrated cervical precancer screening strategy to mitigate the challenges of multiple screening visits and loss to follow-up.

    Effah K, Tekpor E, Wormenor CM, et al.

    Ecancermedicalscience 2023; (17()):1645 doi:10.3332/ecancer.2023.1645.

    PMID: 38414966
  14. 14

    Additional Diagnostic Yield of Endocervical Curettage in Type 3 Transformation Zone for High-Grade Cervical Lesions: A Retrospective Analysis by Human Papillomavirus Genotype.

    Rusu EL, Buciu VB, Balan L, et al.

    Diagnostics (Basel, Switzerland) 2026; (16(8)) doi:10.3390/diagnostics16081220.

    PMID: 42072845
  15. 15

    Chronic Cervicitis: Presenting Features and Response to Therapy.

    Mattson SK, Polk JP, Nyirjesy P

    Journal of lower genital tract disease 2016; (20(3)):e30-3 doi:10.1097/LGT.0000000000000225.

    PMID: 27243142
  16. 16

    A Clinical Conundrum: Chronic Cervicitis.

    Hester EE, Middleman AB

    Journal of pediatric and adolescent gynecology 2019; (32(3)):342-344 doi:10.1016/j.jpag.2018.12.004.

    PMID: 30582974
  17. 17

    An integrative investigation of the therapeutic mechanism of Ainsliaea fragrans Champ. in cervicitis using liquid chromatography tandem mass spectrometry based on a rat plasma metabolomics strategy.

    Zhang X, He M, Lei S, et al.

    Journal of pharmaceutical and biomedical analysis 2018; (156()):221-231 doi:10.1016/j.jpba.2018.04.048.

    PMID: 29729635
  18. 18

    Characteristics of Cervical Cancer Caused by the Human Papillomavirus 18 and Its Genetic Variations in Vietnamese Women.

    Hung TM, Son HX, Bang LVN, Van Duyet L

    Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases 2024; (117()):105546 doi:10.1016/j.meegid.2023.105546.

    PMID: 38176603

This page is for informational purposes only and does not constitute medical advice. Your gynecologist or pathologist should interpret your report and advise whether you need infection testing or follow-up.